Evaluating the prognostic value and functional roles of transcription factor AP4 in colorectal cancer

Yang,Jie; Ma,Jin‑Ping; Xiao,Siyu; Zhang,Xin‑Hua; Xu,Jian‑Bo; Chen,Chuang‑Qi; Cai,Shi‑Rong; He,Yu‑Long

doi:10.3892/ol.2018.8290

Evaluating the prognostic value and functional roles of transcription factor AP4 in colorectal cancer

Authors:
- Jie Yang
- Jin‑Ping Ma
- Siyu Xiao
- Xin‑Hua Zhang
- Jian‑Bo Xu
- Chuang‑Qi Chen
- Shi‑Rong Cai
- Yu‑Long He
View Affiliations

Affiliations: Department of Gastrointestinal Surgery, The First Affiliated Hospital of Sun Yat‑sen University, Guangzhou, Guangdong 510080, P.R. China, Department of Clinical Laboratory, The Sixth Affiliated Hospital of Sun Yat‑sen University, Guangzhou, Guangdong 510655, P.R. China
Published online on: March 16, 2018 https://doi.org/10.3892/ol.2018.8290
Pages: 7545-7554
Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The basic helix-loop-helix transcription factor AP4 (TFAP4) gene serves an important function in the genesis and progression of tumors. However, few studies to date have defined the role of this gene in colorectal cancer (CRC). The aim of the present study was to assess the expression of TFAP4 in CRC and its impact on the prognosis of patients with CRC. In the present study, the expression of TFAP4 was detected in 30 matched pairs of fresh CRC tissues, 187 cases of clinical paraffin‑embedded CRC tissues and CRC cell lines using the reverse transcriptase‑quantitative polymerase chain reaction, immunohistochemistry or western blot analysis. Survival analysis was based on TFAP4 expression. The effects of TFAP4 on CRC cell function were investigated by ectopic expression or knockdown of TFAP4 in vitro. TFAP4 expression was revealed to be increased in human CRC tissues and cell lines. The overall survival (OS) time of patients with high TFAP4 expression was significantly decreased compared with patients with low TFAP4 expression (P<0.001). In addition, TFAP4 was revealed to be an independent prognostic factor for the OS time of patients with CRC (hazard ratio, 2.607; 95% confidence interval, 1.469‑4.627; P=0.001). Ectopic TFAP4 expression promoted CRC cell proliferation, migration and invasion in vitro, and the silencing of TFAP4 expression resulted in the inhibition of these events. These results demonstrated that TFAP4, which was overexpressed in CRC tissues and cell lines, increased the malignant potential of CRC cells and may serve as an indicator for poor prognosis in patients with CRC.

View Figures

View References

1	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
2	Pritchard CC and Grady WM: Colorectal cancer molecular biology moves into clinical practice. Gut. 60:116–129. 2011. View Article : Google Scholar : PubMed/NCBI
3	Augestad KM, Bakaki PM, Rose J, Crawshaw BP, Lindsetmo RO, Dørum LM, Koroukian SM and Delaney CP: Metastatic spread pattern after curative colorectal cancer surgery. A retrospective, longitudinal analysis. Cancer Epidemiol. 39:734–744. 2015. View Article : Google Scholar : PubMed/NCBI
4	Luo HY and Xu RH: Predictive and prognostic biomarkers with therapeutic targets in advanced colorectal cancer. World J Gastroenterol. 20:3858–3874. 2014. View Article : Google Scholar : PubMed/NCBI
5	Hu YF, Lüscher B, Admon A, Mermod N and Tjian R: Transcription factor AP-4 contains multiple dimerization domains that regulate dimer specificity. Genes Dev. 4:1741–1752. 1990. View Article : Google Scholar : PubMed/NCBI
6	Atchley WR and Fitch WM: A natural classification of the basic helix-loop-helix class of transcription factors. Proc Natl Acad Sci USA. 94:5172–5176. 1997. View Article : Google Scholar : PubMed/NCBI
7	Jung P and Hermeking H: The c-MYC-AP4-p21 cascade. Cell Cycle. 8:982–989. 2009. View Article : Google Scholar : PubMed/NCBI
8	Kim MY, Jeong BC, Lee JH, Kee HJ, Kook H, Kim NS, Kim YH, Kim JK, Ahn KY and Kim KK: A repressor complex, AP4 transcription factor and geminin, negatively regulates expression of target genes in nonneuronal cells. Proc Natl Acad Sci USA. 103:13074–13079. 2006. View Article : Google Scholar : PubMed/NCBI
9	Jackstadt R and Hermeking H: AP4 is required for mitogen- and c-MYC-induced cell cycle progression. Oncotarget. 5:7316–7327. 2014. View Article : Google Scholar : PubMed/NCBI
10	Jackstadt R, Jung P and Hermeking H: AP4 directly downregulates p16 and p21 to suppress senescence and mediate transformation. Cell Death Dis. 4:e7752013. View Article : Google Scholar : PubMed/NCBI
11	Jung P, Menssen A, Mayr D and Hermeking H: AP4 encodes a c-MYC-inducible repressor of p21. Proc Natl Acad Sci USA. 105:15046–15051. 2008. View Article : Google Scholar : PubMed/NCBI
12	Jackstadt R, Röh S, Neumann J, Jung P, Hoffmann R, Horst D, Berens C, Bornkamm GW, Kirchner T, Menssen A and Hermeking H: AP4 is a mediator of epithelial-mesenchymal transition and metastasis in colorectal cancer. J Exp Med. 210:1331–1350. 2013. View Article : Google Scholar : PubMed/NCBI
13	Amin S, Kumar A, Nilchi L, Wright K and Kozlowski M: Breast cancer cells proliferation is regulated by tyrosine phosphatase SHP1 through c-jun N-terminal kinase and cooperative induction of RFX-1 and AP-4 transcription factors. Mol Cancer Res. 9:1112–1115. 2011. View Article : Google Scholar : PubMed/NCBI
14	Xinghua L, Bo Z, Yan G, Lei W, Changyao W, Qi L, Lin Y, Kaixiong T, Guobin W and Jianying C: The overexpression of AP-4 as a prognostic indicator for colorectal carcinoma. Med Oncol. 29:871–877. 2012. View Article : Google Scholar : PubMed/NCBI
15	Hu BS, Zhao G, Yu HF, Chen K, Dong JH and Tan JW: High expression of AP-4 predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy. Tumour Biol. 34:271–276. 2013. View Article : Google Scholar : PubMed/NCBI
16	Edge SB, Byrd SR, Compton CC, et al: AJCC cancer staging manual. 7th edition. Springer-Verlag; New York (NY): pp. 143–164. 2010
17	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
18	Mermod N, Williams TJ and Tjian R: Enhancer binding factors AP-4 and AP-1 act in concert to activate SV40 late transcription in vitro. Nature. 332:557–561. 1988. View Article : Google Scholar : PubMed/NCBI
19	Tsujimoto K, Ono T, Sato M, Nishida T, Oguma T and Tadakuma T: Regulation of the expression of caspase-9 by the transcription factor activator protein-4 in glucocorticoid-induced apoptosis. J Biol Chem. 280:27638–27644. 2005. View Article : Google Scholar : PubMed/NCBI
20	Liu X, Zhang B, Guo Y, Liang Q, Wu C, Wu L, Tao K, Wang G and Chen J: Down-regulation of AP-4 inhibits proliferation, induces cell cycle arrest and promotes apoptosis in human colorectal cancer cells. PLoS One. 7:e370962012. View Article : Google Scholar : PubMed/NCBI
21	Zirbes TK, Baldus SE, Moenig SP, Nolden S, Kunze D, Shafizadeh ST, Schneider PM, Thiele J, Hoelscher AH and Dienes HP: Prognostic impact of p21/waf1/cip1 in colorectal cancer. Int J Cancer. 89:14–18. 2000. View Article : Google Scholar : PubMed/NCBI
22	Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW and Vogelstein B: Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science. 282:1497–1501. 1998. View Article : Google Scholar : PubMed/NCBI
23	Cancer Genome Atlas Network, . Muzny DM, Bainbridge MN, Chang K, Dinh HH, Drummond JA, Fowler G, Kovar CL, Lewis L, Morgan MB, et al: Comprehensive molecular characterization of human colon and rectal cancer. Nature. 487:330–337. 2012. View Article : Google Scholar : PubMed/NCBI